AIMS: Silver nanoparticles exhibit unique antibacterial properties that make these ideal candidates for biological and medical applications. We utilized a clean method involving a single synthetic step to prepare silver nanoparticles that exhibit antimicrobial activity. MATERIALS & METHODS: These nanoparticles were prepared by reducing silver nitrate with diaminopyridinylated heparin (DAPHP) and hyaluronan (HA) polysaccharides and tested for their efficacy in inhibiting microbial growth. RESULTS & DISCUSSION: The resulting silver nanoparticles exhibit potent antimicrobial activity against Staphylococcus aureus and modest activity against Escherichia coli. Silver-HA showed greater antimicrobial activity than silver-DAPHP, while silver-glucose nanoparticles exhibited very weak antimicrobial activity. Neither HA nor DAPHP showed activity against S. aureus or E. coli. CONCLUSION: These results suggest that DAPHP and HA silver nanoparticles have potential in antimicrobial therapeutic applications.
AIMS: Silver nanoparticles exhibit unique antibacterial properties that make these ideal candidates for biological and medical applications. We utilized a clean method involving a single synthetic step to prepare silver nanoparticles that exhibit antimicrobial activity. MATERIALS & METHODS: These nanoparticles were prepared by reducing silver nitrate with diaminopyridinylated heparin (DAPHP) and hyaluronan (HA) polysaccharides and tested for their efficacy in inhibiting microbial growth. RESULTS & DISCUSSION: The resulting silver nanoparticles exhibit potent antimicrobial activity against Staphylococcus aureus and modest activity against Escherichia coli. Silver-HA showed greater antimicrobial activity than silver-DAPHP, while silver-glucose nanoparticles exhibited very weak antimicrobial activity. Neither HA nor DAPHP showed activity against S. aureus or E. coli. CONCLUSION: These results suggest that DAPHP and HAsilver nanoparticles have potential in antimicrobial therapeutic applications.
Authors: Jose Ruben Morones; Jose Luis Elechiguerra; Alejandra Camacho; Katherine Holt; Juan B Kouri; Jose Tapia Ramírez; Miguel Jose Yacaman Journal: Nanotechnology Date: 2005-08-26 Impact factor: 3.874
Authors: D A Steinberg; M A Hurst; C A Fujii; A H Kung; J F Ho; F C Cheng; D J Loury; J C Fiddes Journal: Antimicrob Agents Chemother Date: 1997-08 Impact factor: 5.191
Authors: Georg Gosheger; Jendrik Hardes; Helmut Ahrens; Arne Streitburger; Horst Buerger; Michael Erren; Andreas Gunsel; Fritz H Kemper; Winfried Winkelmann; Christof Von Eiff Journal: Biomaterials Date: 2004-11 Impact factor: 12.479
Authors: Sashka Dimitrievska; Chao Cai; Amanda Weyers; Jenna L Balestrini; Tylee Lin; Sumati Sundaram; Go Hatachi; David A Spiegel; Themis R Kyriakides; Jianjun Miao; Guoyun Li; Laura E Niklason; Robert J Linhardt Journal: Acta Biomater Date: 2014-11-20 Impact factor: 8.947
Authors: Bryan Calderón-Jiménez; Monique E Johnson; Antonio R Montoro Bustos; Karen E Murphy; Michael R Winchester; José R Vega Baudrit Journal: Front Chem Date: 2017-02-21 Impact factor: 5.221